As of 2024-12-15, the Relative Valuation of GPX Medical AB (GPXMED.ST) is (5.71) SEK. This relative valuation is based on P/E multiples. With the latest stock price at 2.67 SEK, the upside of GPX Medical AB based on Relative Valuation is -313.9%.
The range of the Relative Valuation is (5.37) - (5.73) SEK.
Note: valuation result may not be accurate due to the company's negative earnings.
Range | Selected | |
Trailing P/E multiples | 14.5x - 19.7x | 18.0x |
Forward P/E multiples | 16.6x - 17.7x | 17.2x |
Fair Price | (5.37) - (5.73) | (5.71) |
Upside | -300.9% - -314.5% | -313.9% |
Date | P/E |